Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Hospitals
  4. /Aster DM Healthcare Ltd
MomentumDeep Value

Aster DM Healthcare Ltd: Why Is It Outperforming Nifty 500?

Active
RS +19.7%Weak4w Streak

In Week of Mar 28, 2026, Aster DM Healthcare Ltd (Hospitals) is outperforming Nifty 500 with +19.7% relative strength. Fundamentals: Weak. On a 4-week streak.

PE: Mid ContractionFalling Knife

What's Happening

🔻Earnings declining and PE falling — fundamentals deteriorating
💪Debt reduced 13% YoY — balance sheet strengthening
👔Promoter stake down 1.5% this quarter
🌐FII stake decreased 5.1% this quarter
🏛️DII accumulation — stake up 5.4%
💰Trading 69% above estimated fair value — significant premium

Earnings Acceleration Triggers

1. Nagarcoil unit ramp-up contributing to growth
Q3 FY26HIGH
2. Specialty mix improvement driving margin expansion
OngoingHIGH
3. Focus units turnaround delivering dramatic improvement
Current quarterHIGH

Key Risks

1. One-time labor code implementation expenses
MEDIUM
2. Capacity constraints limiting growth
MEDIUM

Key Numbers

PAT Growth YoY
-8%
Inflection Down
Revenue YoY
+13%
Accelerating
Operating Margin
17.0%
-100 bps YoY
PE Ratio
96.1
Current Price
₹668
Dividend Yield
0.75%
Fundamental Score
28/100
Weak
3Y PAT CAGR
+80%
Market Cap
34.6K Cr
Valuation
Significantly Overvalued

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

Why Are Aster DM Healthcare Ltd's Earnings Accelerating?

Based on Q3 FY26 earnings • Updated Mar 7, 2026

Nagarcoil unit ramp-up contributing to growth

Expected: Q3 FY26HIGH confidence

What: Newly commissioned Nagarcoil unit launched in October 2024 is already profitably contributing to revenue and EBITDA growth.

“EBITDA growth also reflects the early success of key synergy initiatives including procurement, new clinical talent hiring implemented in the first half for FY26, continued focus on clinical talent recruitment and management, along with the strong ramp up of the Nagarcoil unit launched in October 24 which has already started contributing very profitably in this quarter.”

Specialty mix improvement driving margin expansion

Expected: OngoingHIGH confidence

What: 60bps increase in specialty share to 57.6% and 100bps improvement in payer mix to 80.1% cash/insurance business driving margin expansion.

“Revenue growth during the quarter was driven by increase in IP and OP volume 8% yoy for both improvement in specialty mix with specialty share increasing by 60bps to 57.6% and a very favorable shift in the payer mix as the share of cash and insurance business rose further by 100 basis points to 80.1%.”

Focus units turnaround delivering dramatic improvement

Expected: Current quarterHIGH confidence

What: 29% of total revenue from focus units showing 19.1% YoY revenue growth and 68.1% YoY EBITDA growth with 520bps margin expansion.

“Focus units which is 29% of the total revenue delivered a robust 19.1% YoY growth and 68.1% YoY EBITDA growth and achieved a margin of 17.8% representing 520 BIPS YoY expansion driven by sustained emphasis on operating excellence across the business.”

What Are the Key Risks for Aster DM Healthcare Ltd?

Earnings deceleration risks from management commentary

One-time labor code implementation expenses

MEDIUM

Trigger: Implementation of new labor code provisions

Management view: PAT for the quarter was impacted by one time exceptional expenses related to implementation of new labor code amounting to 27.9 crores. This includes a provision of 26.3 crores towards gratuity and 1.6 crores towards compensated absences.

Monitor: One-time expenses

Capacity constraints limiting growth

MEDIUM

Trigger: Current facilities operating at max capacity

Management view: We are maxed for capacity so we can really take more patients. It's a highly profitable asset for us.

Monitor: Capacity utilization

What Is Aster DM Healthcare Ltd's Management Saying?

Key quotes from recent conference calls

“EBITDA growth also reflects the early success of key synergy initiatives including procurement, new clinical talent hiring implemented in the first half for FY26, continued focus on clinical talent recruitment and management, along with the strong ramp up of the Nagarcoil unit launched in October 24 which has already started contributing very profitably in this quarter. — Management”
“Core hospitals and clinics delivered 18% growth in operating EBITDA with margins improving to 22.8%. Excluding CASA code, the normalized path grew 22% year on year reflecting improved profitability. — Management”
“In patient volumes grew 11% yearonear and 8% excluding carter code indicating healthy underlying demand. — Management”
“The platform delivered revenue growth of 15% yearonear to 2366 crores supported by 9% growth in total patient volumes and 8% growth in... — Management”

What Is Aster DM Healthcare Ltd's Management Guidance?

Forward-looking targets from management for next 2-4 quarters

Management Tone: CAUTIOUS

Key Milestones

• Nagarcoil unit ramp-up

• Specialty mix improvement

• Focus units turnaround

How Fast Is Aster DM Healthcare Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+13%-26%Accelerating
PAT (Net Profit)-8%+80%Inflection Down
OPM17.0%-100 bpsStable

The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 7, 2026.

Other Top Hospitals Stocks Beating Nifty 500

Apollo Hospitals Enterprise Ltd
Average • 6w streak
+17.1%
KMC Speciality Hospitals (India) Ltd
Average • 12w streak
+15.5%
Sakar Healthcare Ltd
Average • 11w streak
+34.0%
← Back to HospitalsDashboard

Frequently Asked Questions: Aster DM Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Aster DM Healthcare Ltd's latest quarterly results?

Aster DM Healthcare Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: -7.8% (inflecting downward)
  • Revenue Growth YoY: +13.0%
  • Operating Margin: 17.0% (stable)

Is Aster DM Healthcare Ltd's profit growing or declining?

Aster DM Healthcare Ltd's profit is declining with an inflecting downward trend.

  • PAT Growth YoY: -7.8% (latest quarter)
  • PAT Growth QoQ: -51.2% (sequential)
  • 3-Year PAT CAGR: +80.0%
  • Trend: Inflecting downward — consistent growth pattern

What is Aster DM Healthcare Ltd's revenue growth trend?

Aster DM Healthcare Ltd's revenue growth trend is accelerating.

  • Revenue Growth YoY: +13.0%
  • Revenue Growth QoQ: -0.9% (sequential)
  • 3-Year Revenue CAGR: -26.1%

How is Aster DM Healthcare Ltd's operating margin trending?

Aster DM Healthcare Ltd's operating margin is stable.

  • Current OPM: 17.0%
  • OPM Change YoY: -1.0% basis points
  • OPM Change QoQ: -3.0% basis points

What is Aster DM Healthcare Ltd's 3-year profit and revenue CAGR?

Aster DM Healthcare Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +80.0%
  • 3-Year Revenue CAGR: -26.1%

Is Aster DM Healthcare Ltd's growth accelerating or decelerating?

Aster DM Healthcare Ltd's earnings growth is inflecting downward with mixed signals on a sequential basis.

  • YoY Acceleration: -22.0% bps
  • Sequential Acceleration: -78.7% bps

What is Aster DM Healthcare Ltd's trailing twelve month (TTM) performance?

Aster DM Healthcare Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹360 Cr
  • TTM PAT Growth: -80.0% YoY
  • TTM Revenue: ₹4,000 Cr
  • TTM Revenue Growth: +8.5% YoY
  • TTM Operating Margin: 18.5%

Is Aster DM Healthcare Ltd overvalued or undervalued?

Aster DM Healthcare Ltd appears significantly overvalued based on our fair value analysis.

  • Valuation Signal: Significantly Overvalued
  • Current PE: 96.1x
  • Price-to-Book: 7.6x

What is Aster DM Healthcare Ltd's current PE ratio?

Aster DM Healthcare Ltd's current PE ratio is 96.1x.

  • Current PE: 96.1x
  • Market Cap: 34.6K Cr
  • Dividend Yield: 0.75%

How does Aster DM Healthcare Ltd's valuation compare to its history?

Aster DM Healthcare Ltd's current PE is 96.1x.

  • Current PE: 96.1x
  • Valuation Assessment: Significantly Overvalued

What is Aster DM Healthcare Ltd's price-to-book ratio?

Aster DM Healthcare Ltd's price-to-book ratio is 7.6x.

  • Price-to-Book (P/B): 7.6x
  • Book Value per Share: ₹88
  • Current Price: ₹668

Is Aster DM Healthcare Ltd a fundamentally strong company?

Aster DM Healthcare Ltd is rated Weak with a fundamental score of 27.56/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +13.0% (10% weight)
  • PAT Growth YoY: -7.8% (10% weight)
  • PAT Growth QoQ: -51.2% (10% weight)
  • Margins stable (10% weight)

Is Aster DM Healthcare Ltd debt free?

Aster DM Healthcare Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹2,000 Cr

What is Aster DM Healthcare Ltd's return on equity (ROE) and ROCE?

Aster DM Healthcare Ltd's return ratios over recent years

  • FY2023: ROCE 3.0%
  • FY2024: ROCE 4.0%
  • FY2025: ROCE 11.0%

Is Aster DM Healthcare Ltd's cash flow positive?

Aster DM Healthcare Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹425 Cr
  • Free Cash Flow (FCF): ₹6,000 Cr
  • CFO/PAT Ratio: 8% (weak cash conversion)

What is Aster DM Healthcare Ltd's dividend yield?

Aster DM Healthcare Ltd's current dividend yield is 0.75%.

  • Dividend Yield: 0.75%
  • Current Price: ₹668

Who holds Aster DM Healthcare Ltd shares — promoters, FII, DII?

Aster DM Healthcare Ltd's shareholding pattern (Dec 2025)

  • Promoters: 40.4%
  • FII (Foreign): 18.5%
  • DII (Domestic): 26.1%
  • Public: 14.8%

Is promoter holding increasing or decreasing in Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 40.4% (Dec 2025)
  • Previous Quarter: 40.4% (Sep 2025)
  • Change: 0.00% (stable)

How long has Aster DM Healthcare Ltd been outperforming Nifty 500?

Aster DM Healthcare Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.

Is Aster DM Healthcare Ltd a new momentum entry or an established outperformer?

Aster DM Healthcare Ltd is an established outperformer with 4 weeks of consecutive Nifty 500 outperformance.

What are the growth catalysts for Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd has 3 key growth catalysts identified from recent earnings analysis

  • Nagarcoil unit ramp-up contributing to growth
  • Specialty mix improvement driving margin expansion
  • Focus units turnaround delivering dramatic improvement

What are the key risks in Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd has 2 key risks worth monitoring

  • One-time labor code implementation expenses
  • Capacity constraints limiting growth

What did Aster DM Healthcare Ltd's management say in the latest earnings call?

In Q3 FY26, Aster DM Healthcare Ltd's management highlighted

  • "EBITDA growth also reflects the early success of key synergy initiatives including procurement, new clinical talent hiring implemented in the first ha..."
  • "Core hospitals and clinics delivered 18% growth in operating EBITDA with margins improving to 22.8%. Excluding CASA code, the normalized path grew 22%..."
  • "In patient volumes grew 11% yearonear and 8% excluding carter code indicating healthy underlying demand. — Management"

What is Aster DM Healthcare Ltd's management guidance for growth?

Aster DM Healthcare Ltd's management has provided the following forward guidance for next 2-4 quarters

  • Management tone: cautious
  • Milestone: Nagarcoil unit ramp-up
  • Milestone: Specialty mix improvement

Is Aster DM Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Aster DM Healthcare Ltd may be worth studying

  • Revenue growth is accelerating — +13.0% YoY
  • Cash flow is positive — CFO ₹425 Cr

What is the investment thesis for Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd investment thesis summary:

Research Signals (Bull Case)

  • Revenue growing at +13.0% YoY
  • Growth catalyst: Nagarcoil unit ramp-up contributing to growth

Risk Factors (Bear Case)

  • Appears significantly overvalued
  • Key risk: One-time labor code implementation expenses

What is the future outlook for Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd's forward outlook based on current data signals

  • Earnings Trend: inflecting downward
  • Revenue Trend: accelerating
  • Margin Trend: stable
  • Valuation: Significantly Overvalued
  • Key Catalyst: Nagarcoil unit ramp-up contributing to growth
  • Key Risk: One-time labor code implementation expenses

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.